摘要 |
<p>The invention consists of the use of the HIP/PAP protein or a protein derivative thereof for use for manufacturing a medicament for preventing or treating a disease selected from the group consisting of - a neonatal brain injury, which includes a neonatal brain injury caused by a brain hypoxia, - an adult or child brain injury, which includes an adult or child brain injury caused by a brain hypoxia, - an adult or child or neonatal traumatic brain injury, - a cerebellar disease or disorder, and - a disease involving a defect in the production or in the phosphorylation of Gap-43.</p> |
申请人 |
ALFACT INNOVATION;FAIVRE, JAMILA;GRESSENS, PIERRE;AMOUYAL, GILLES;AMOUYAL, PAUL;BRECHOT, CHRISTIAN;ROUGIER, ELODIE |
发明人 |
FAIVRE, JAMILA;GRESSENS, PIERRE;AMOUYAL, GILLES;AMOUYAL, PAUL;BRECHOT, CHRISTIAN;ROUGIER, ELODIE |